Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding

PHASE3UnknownINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2018

Conditions
Menorrhagia
Interventions
DEVICE

AEGEA Vapor System(TM)

vapor endometrial ablation

Trial Locations (15)

10467

Montefiore Medical Center, The Bronx

27713

Carolina Women's Research and Wellness Center/OB-GYN, Durham

32801

Clinical Associates of Orlando, LLC, Orlando

33414

Visions Clinical Research, Wellington

37404

Chattanooga Medical Research, LLC, Chattanooga

47630

Basinksi, LLC, Newburgh

55435

Minnesota Gynecology & Surgery, Edina

60173

The Advanced Gynecologic Surgery Institute, Naperville

63141

Mercy Hospital, St Louis

76104

Baylor All Saints, Fort Worth

83404

Rosemark WomenCares Specialists, Idaho Falls

06051

Center for Fertility and Women's Health, New Britain

L8N 3Z5

Department of Obstetrics and Gynecology, Hamilton

Unknown

Hospital Universitario de la Universidad Autonoma de Nuevo Leon, Monterrey

8025 AB

Isala Klinieken, Zwolle

Sponsors
All Listed Sponsors
lead

Aegea Medical, Inc.

INDUSTRY

NCT01979861 - Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding | Biotech Hunter | Biotech Hunter